 LONDON and NEW YORK, Sept. 28, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences plc Nasdaq: TLSA LSE: TILS Tiziana or the Company, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has been notified that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman has a beneficial interest, purchased 100,000 ordinary shares of 3p each in the market at a price of 52p per share. 